KENNETH BATE Insider Trading $CATB CATABASIS PHARMACEUTICALS INC
Get free email notifications about insider trading for KENNETH BATE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH BATE. KENNETH BATE is EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Epizyme, Inc. ($EPZM).
KENNETH BATE in CATABASIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 02 2021
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KENNETH BATE in CATABASIS PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, BMRN, CATB, EPZM, GNCA, SNTA, MLNM, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2021 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 2.04 | 100,000 | 204,000 | 100,000 | |
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 05 2019 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 6.53 | 7,500 | 48,975 | 7,500 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Aug 05 2016 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 4.55 | 6,500 | 29,575 | 6,500 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 |
Page: 1